News.
Stay up to date with the latest news about our innovation initiatives
Published on 02/01/2020
Almirall + Iktos = Artificial Intelligence for drug design
Generative modelling AI technology for a quick identification of molecules with multiple bioactivity and drug-like criteria.
Almirall is launching a call for start-ups to develop digital health solutions for dermatological challenges.
We aim to establish collaborations to find innovative targets, pathways or therapies in medical dermatology.
Almirall and HitGen entered in a multi-target research collaboration to develop new therapies for atopic dermatitis.
More than 450 scientists subscribed and over 170 different proposals received.
